Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT)
T. A. Alexandrina, S. A. Cherenko, M. S. Cherenko (Kiev, Riev, Ukraine)
Source: Annual Congress 2005 - Biological and treatment aspects of tuberculosis
Session: Biological and treatment aspects of tuberculosis
Session type: Poster Discussion
Number: 2912
Disease area: Respiratory infections
Abstract More than a quarter of subjects, whom IPT was indicated, failed to complete it. Since 2003 in some regions of Ukraine voluntary HIV counseling and testing (VCT) program has been implemented. Before 2003 we used only voluntary HIV testing (VT). The aim was to assess the impact of VCT on patients adherence of IPT. VCT targeted to improve tuberculosis education among HIV-infected patients. In retrospective study we compared acceptance level of PPD skin testing and adherence level of IPT in patients who were notified in 2002 before implementation of VCT in Kiev and in 2003 after implementation this program. In Kiev in 2002 were notified 372 patients with HIV/AIDS, in 2003 — 841. In 2002 182 (48,9%) patients were agreed to perform PPD skin test and 70 (38,4%) from them completed it. These proportions increased significantly in 2003 after posttest counseling — 825 (98,1%) and 554 (67,2%) respectively, p<0,01. In result of PPD screening 42 patients, who didn‘t were counseled, were indicated to IPT, 17 (40,5 %) of them completed it. Among posttest counseled patients IPT was indicated for 402 patients and 292 (72,6%)of them completed it. So, proportion patients, who completed IPT, was significantly higher in case of conducting posttest counseling, p<0,05. Conclusion. VCT significantly increases acceptance level of PPD skin testing and adherence level of IPT.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. A. Alexandrina, S. A. Cherenko, M. S. Cherenko (Kiev, Riev, Ukraine). Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT). Eur Respir J 2005; 26: Suppl. 49, 2912
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Choice and adherence in preventive treatment for tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003
Impact of pre-test voluntary counseling on notification of HIV-infection in patients with tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 650s Year: 2005
The effect of education on adherence to tuberculosis therapy Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004
Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007
Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment Source: Eur Respir J 2006; 28: Suppl. 50, 589s Year: 2006
Effectiveness of a personalized smoking cessation counseling program in patients with oral cancer: preliminary results Source: International Congress 2017 – Smoking cessation Year: 2017
Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children Source: Eur Respir J, 57 (1) 2001756; 10.1183/13993003.01756-2020 Year: 2021
Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review Source: Eur Respir J, 53 (1) 1801030; 10.1183/13993003.01030-2018 Year: 2019
An intervention to modify patients‘ beliefs about maintenance therapy and improve adherence to medication Source: Eur Respir J 2005; 26: Suppl. 49, 46s Year: 2005
Experience of isofon use for therapy and chemoprophylaxis of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 486s Year: 2004
Barriers and facilitators of a latent tuberculosis screening and treatment programme of recent migrants Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Intervention study to evaluate effectiveness of integrated therapy (varenicline plus montivational interviewing) for smoking cessation in diabetic patients: Source: Annual Congress 2012 - Smoking tobacco: from second hand to earthquake Year: 2012
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006